BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38780484)

  • 1. Calcium-sensing Receptor, a Potential Biomarker Revealed by Large-scale Public Databases and Experimental Verification in Metastatic Breast Cancer.
    Xie W; Xu H; Cheng Y; Lin X; Zeng J; Sun Y
    Technol Cancer Res Treat; 2024; 23():15330338241254219. PubMed ID: 38780484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and characterization of calcium sensing receptor null cells: a highly malignant and drug resistant phenotype of colon cancer.
    Singh N; Liu G; Chakrabarty S
    Int J Cancer; 2013 May; 132(9):1996-2005. PubMed ID: 23055106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium-sensing receptor promotes tumor proliferation and migration in human intrahepatic cholangiocarcinoma by targeting ERK signaling pathway.
    Fang Y; Liu L; Liu S; Hu L; Cai W; Wan X; Liu D; He Y; Zhu Z
    Eur J Pharmacol; 2020 Apr; 872():172915. PubMed ID: 31926993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated analysis identifies TfR1 as a prognostic biomarker which correlates with immune infiltration in breast cancer.
    Chen F; Fan Y; Hou J; Liu B; Zhang B; Shang Y; Chang Y; Cao P; Tan K
    Aging (Albany NY); 2021 Sep; 13(17):21671-21699. PubMed ID: 34518441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and potential molecular mechanisms of miR‑204‑5p in breast cancer, based on bioinformatics and a meta‑analysis of 2,306 cases.
    Cai KT; Liu AG; Wang ZF; Jiang HW; Zeng JJ; He RQ; Ma J; Chen G; Zhong JC
    Mol Med Rep; 2019 Feb; 19(2):1168-1184. PubMed ID: 30569120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast growth factor receptor splice variants are stable markers of oncogenic transforming growth factor β1 signaling in metastatic breast cancers.
    Wendt MK; Taylor MA; Schiemann BJ; Sossey-Alaoui K; Schiemann WP
    Breast Cancer Res; 2014 Mar; 16(2):R24. PubMed ID: 24618085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulated miR‑203a‑3p and its potential molecular mechanism in breast cancer: A study based on bioinformatics analyses and a comprehensive meta‑analysis.
    Cai KT; Feng CX; Zhao JC; He RQ; Ma J; Zhong JC
    Mol Med Rep; 2018 Dec; 18(6):4994-5008. PubMed ID: 30320391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of calcium sensing receptor (CaSR) in tumorigenesis.
    Singh N; Promkan M; Liu G; Varani J; Chakrabarty S
    Best Pract Res Clin Endocrinol Metab; 2013 Jun; 27(3):455-63. PubMed ID: 23856272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel biomarkers in breast cancer via integrated bioinformatics analysis and experimental validation.
    Wang N; Zhang H; Li D; Jiang C; Zhao H; Teng Y
    Bioengineered; 2021 Dec; 12(2):12431-12446. PubMed ID: 34895070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feature genes in metastatic breast cancer identified by MetaDE and SVM classifier methods.
    Tuo Y; An N; Zhang M
    Mol Med Rep; 2018 Mar; 17(3):4281-4290. PubMed ID: 29328377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative Bioinformatics Analysis Reveals Potential Target Genes and TNFα Signaling Inhibition by Brazilin in Metastatic Breast Cancer Cells.
    Hermawan A; Putri H
    Asian Pac J Cancer Prev; 2020 Sep; 21(9):2751-2762. PubMed ID: 32986377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SAP domain-dependent Mkl1 signaling stimulates proliferation and cell migration by induction of a distinct gene set indicative of poor prognosis in breast cancer patients.
    Gurbuz I; Ferralli J; Roloff T; Chiquet-Ehrismann R; Asparuhova MB
    Mol Cancer; 2014 Feb; 13():22. PubMed ID: 24495796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Key Biomarkers and Potential Molecular Mechanisms in Renal Cell Carcinoma by Bioinformatics Analysis.
    Li F; Guo P; Dong K; Guo P; Wang H; Lv X
    J Comput Biol; 2019 Nov; 26(11):1278-1295. PubMed ID: 31233342
    [No Abstract]   [Full Text] [Related]  

  • 14. Elevated Expression of RIOK1 Is Correlated with Breast Cancer Hormone Receptor Status and Promotes Cancer Progression.
    Huang Z; Li X; Xie T; Gu C; Ni K; Yin Q; Cao X; Zhang C
    Cancer Res Treat; 2020 Oct; 52(4):1067-1083. PubMed ID: 32599985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium-sensing-receptor (CaSR) controls IL-6 secretion in metastatic breast cancer MDA-MB-231 cells by a dual mechanism revealed by agonist and inverse-agonist modulators.
    Hernández-Bedolla MA; González-Domínguez E; Zavala-Barrera C; Gutiérrez-López TY; Hidalgo-Moyle JJ; Vázquez-Prado J; Sánchez-Torres C; Reyes-Cruz G
    Mol Cell Endocrinol; 2016 Nov; 436():159-68. PubMed ID: 27477783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the key pathways and genes involved in HER2-positive breast cancer with brain metastasis.
    Lu X; Gao C; Liu C; Zhuang J; Su P; Li H; Wang X; Sun C
    Pathol Res Pract; 2019 Aug; 215(8):152475. PubMed ID: 31178227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High SET Domain Bifurcated 1 (SETDB1) Expression Predicts Poor Prognosis in Breast Carcinoma.
    Zhou Z; Wu B; Tang X; Yang W; Zou Q; Wang H
    Med Sci Monit; 2020 Apr; 26():e922982. PubMed ID: 32305991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Value of miR-101-3p and Biological Analysis of its Prospective Targets in Breast Cancer: A Study Based on The Cancer Genome Atlas (TCGA) and Bioinformatics.
    Li CY; Xiong DD; Huang CQ; He RQ; Liang HW; Pan DH; Wang HL; Wang YW; Zhu HW; Chen G
    Med Sci Monit; 2017 Apr; 23():1857-1871. PubMed ID: 28416776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium-Sensing Receptor Expression in Breast Cancer.
    Busic-Pavlek I; Dumic-Cule I; Kovacevic L; Milosevic M; Delimar P; Korsa L; Marusic Z; Prutki M
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of androgen receptor expression on clinical characterization of metastatic breast cancer.
    Kim JY; Park K; Lee E; Jung HH; Ahn JS; Im YH; Park WY; Park YH
    Oncotarget; 2017 Jan; 8(5):8693-8706. PubMed ID: 28060723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.